Artificial intelligence (AI) is increasingly transforming the landscape of diabetes diagnosis and treatment by leveraging data-driven approaches to enhance precision and efficiency in healthcare. AI algorithms analyze vast amounts of patient data, including medical records, genetic profiles, and real-time physiological metrics from wearable devices, to identify patterns and predict disease progression. In diagnostics, AI-powered systems can interpret complex datasets to facilitate early detection of diabetes and its complications, such as diabetic retinopathy and nephropathy, improving clinical outcomes through timely intervention. Furthermore, AI algorithms aid in personalized treatment strategies by optimizing insulin dosing regimens based on individual patient characteristics and response patterns. Machine learning models continue to evolve, offering healthcare providers decision support tools that streamline care delivery, enhance patient monitoring, and tailor therapeutic interventions to achieve better glycemic control and mitigate long-term complications of diabetes mellitus. As AI technologies advance, their integration into clinical practice holds promise for revolutionizing diabetes management, fostering proactive healthcare strategies, and ultimately improving patient outcomes.